Clinical and Experimental Pharmacology and Physiology · 1985 · 33 citations · 13 references
MedicineNeurosciencePharmacologyBiochemical PharmacologyNeurochemistryNeuropharmacologyCholinergic NeurochemistryCholinergic PharmacologyEnzyme InhibitionAcetylcholine PharmacologyAcetylcholinesterase FunctionAcetylcholinesterase InhibitorsAche InhibitionAnticholinergic DrugsAntimalarial AgentsAntimuscarinic DrugsButyrylcholinesterase Inhibition
The characteristics of the inhibition of electric eel acetylcholinesterase (AChE) and horse serum butyrylcholinesterase (BChE) by the antimalarial agents mefloquine, chloroquine, amodiaquine and amopyroquine were determined. The antimalarials were found to be non-competitive inhibitors of both AChE and BChE. In both enzyme systems, inhibitory potencies were in the order amodiaquine greater than amopyroquine greater than chloroquine greater than mefloquine. The low inhibitory potency of mefloquine may account in part for the appearance of gastrointestinal and central nervous system disturbances only at high doses of the drug.
13
Martindale: The Extra Pharmacopoeia
Paul Turner · Postgraduate Medical Journal · 1983 · 117 citations · Full text
Hydrophobic binding site in acetylcholinesterase
George M. Steinberg, Morton L. Mednick, J.P. Maddox et al. · Journal of Medicinal Chemistry · 1975 · 75 citations
Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
E. B. Doberstyn, P Phintuyothin, S. Noeypatimanondh et al. · PubMed · 1979 · 73 citations
Inhibition of histamine methylation by antimalarial drugs
Victor Cohn · Biochemical Pharmacology · 1965 · 61 citations